Board Meeting

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE264.107.5 (+2.92 %)
PREV CLOSE ( ) 256.60
OPEN PRICE ( ) 257.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1492284
TODAY'S LOW / HIGH ( )257.55 266.70
52 WK LOW / HIGH ( )199.3 307
NSE264.157.55 (+2.94 %)
PREV CLOSE( ) 256.60
OPEN PRICE ( ) 260.00
BID PRICE (QTY) 264.15 (8622)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7744310
TODAY'S LOW / HIGH( ) 259.20 266.75
52 WK LOW / HIGH ( )199.25 307.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.